Evidence map›Paper›PMID 22698888›Full record

ReviewThe Lancet. Neurology2012

Intracerebral haemorrhage: mechanisms of injury and therapeutic targets.

Richard F Keep, Ya Hua, Guohua Xi

2 registry-linked trialsAbstract readReview
In one paragraph

Review in The Lancet. Neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 722 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
722citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03741530 nacompletednot on this mapstarted 2018, after this paper: background citation

Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage (GATE-ICH): a Multi-center Randomized, Controlled, Assessor-blinded Trial

TypeinterventionalSponsorXijing HospitalRan2018 to 2020Enrolled220ConditionsIntracerebral HemorrhageArmsGlibenclamide Tablets, Standard management for ICH
NCT04088630 early_phase1completednot on this mapstarted 2020, after this paper: background citation

Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage

TypeinterventionalSponsorWake Forest University Health SciencesRan2020 to 2024Enrolled28ConditionsIntracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic, Intracerebral Hemorrhage, HypertensiveArmsFingolimod, Placebo, Open-label Fingolimod
3 · Its place in the literature

Who cites it

722 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Surgery for spontaneous supratentorial intracerebral haemorrhage.The Cochrane database of systematic reviews · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

662 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Richard F KeepDepartment of Neurosurgery, University of Michigan, Ann Arbor, MI 48109, USA. rkeep@umich.edu
Ya Hua
Guohua Xi

Funding

Endothelial Preconditioning and Ischemic Brain InjuryR01NS034709 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KEEP, RICHARD F · 1996 to 2013
$3.6M
MECHANISMS OF THROMBIN INDUCED TOLERANCE TO BRAIN INJURYR01NS039866 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XI, GUOHUA · 2000 to 2011
$2.8M
Mechanisms of Brain Injury after Intraventricular HemorrhageR01NS073595 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI XI, GUOHUA · 2012 to 2016
$1.7M
Estrogen effects on complement-mediated brain injury in intracerebral hemorrhageR01NS057539 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUA, YA · 2008 to 2011
$1.1M
NINDS NIH HHS NS-034709NINDS NIH HHS NS-039866NINDS NIH HHS NS-057539NINDS NIH HHS NS 073595NINDS NIH HHS R01 NS034709NINDS NIH HHS R01 NS039866NINDS NIH HHS R01 NS057539NINDS NIH HHS R01 NS073595
6 · The paper itself

Abstract

Intracerebral haemorrhage accounts for about 10-15% of all strokes and is associated with high mortality and morbidity. No successful phase 3 clinical trials for this disorder have been completed. In the past 6 years, the number of preclinical and clinical studies focused on intracerebral haemorrhage has risen. Important advances have been made in animal models of this disorder and in our understanding of mechanisms underlying brain injury after haemorrhage. Several therapeutic targets have subsequently been identified that are now being pursued in clinical trials. Many clinical trials have been based on limited preclinical data, and guidelines to justify taking preclinical results to the clinic are needed.

Indexed as

Cerebral HemorrhageHumansStroke

Identifiers

PMID22698888
PMCPMC3884550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.